Not only does the PARP enzyme repair DNA damage and help in tumour progression, but it also develops resistance to radiotherapy in cancer cells negative in XRCC2 (X-ray repair complementing defective repair in Chinese hamster cells 2 gene) [7,8]. This evidence concerns the gene PARP1 and cancer.